CRIS Current Research Information System

PAROLIN, CAROLA ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.286
AS - Asia 9.850
EU - Europa 8.232
AF - Africa 680
SA - Sud America 462
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 4
Totale 29.543
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.077
IT - Italia 3.087
SG - Singapore 2.553
CN - Cina 2.484
VN - Vietnam 2.303
GB - Regno Unito 1.493
DE - Germania 843
HK - Hong Kong 716
SE - Svezia 624
IN - India 470
FR - Francia 455
BR - Brasile 334
RU - Federazione Russa 326
NL - Olanda 315
BD - Bangladesh 301
UA - Ucraina 223
IE - Irlanda 222
KR - Corea 205
ZA - Sudafrica 170
CI - Costa d'Avorio 158
PK - Pakistan 158
JP - Giappone 150
CA - Canada 125
FI - Finlandia 122
TG - Togo 109
SC - Seychelles 98
PL - Polonia 72
ID - Indonesia 71
EE - Estonia 68
AR - Argentina 67
CH - Svizzera 60
BE - Belgio 58
TH - Thailandia 55
PH - Filippine 54
NG - Nigeria 52
TR - Turchia 49
JO - Giordania 48
BG - Bulgaria 44
ES - Italia 43
MX - Messico 42
TW - Taiwan 40
AT - Austria 38
IQ - Iraq 37
IR - Iran 35
GR - Grecia 33
MY - Malesia 25
AU - Australia 24
EG - Egitto 24
HR - Croazia 23
CL - Cile 17
LT - Lituania 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
DZ - Algeria 14
MA - Marocco 14
RO - Romania 14
LB - Libano 13
EC - Ecuador 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
KE - Kenya 8
AL - Albania 7
CO - Colombia 7
PE - Perù 7
PT - Portogallo 7
UY - Uruguay 7
BB - Barbados 6
GH - Ghana 6
JM - Giamaica 6
TN - Tunisia 6
ET - Etiopia 5
HU - Ungheria 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
SN - Senegal 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
IL - Israele 4
NP - Nepal 4
QA - Qatar 4
BZ - Belize 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
SV - El Salvador 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BW - Botswana 2
CR - Costa Rica 2
GE - Georgia 2
KG - Kirghizistan 2
KH - Cambogia 2
MK - Macedonia 2
MM - Myanmar 2
MT - Malta 2
NI - Nicaragua 2
Totale 29.502
Salva come PNG Salva come JPEG
Città #
Singapore 1.802
Ashburn 1.578
Southend 1.242
Chandler 700
San Jose 663
Hong Kong 654
Bologna 629
Ho Chi Minh City 470
Santa Clara 467
Fairfield 432
Hanoi 380
Dong Ket 369
Hefei 366
Ann Arbor 335
Beijing 307
Houston 263
Princeton 262
Los Angeles 251
Boardman 249
Seattle 242
New York 238
Wilmington 237
Dallas 229
Woodbridge 216
Dublin 215
Cambridge 180
Frankfurt am Main 172
Seoul 166
Milan 159
Abidjan 158
Council Bluffs 147
Lauterbourg 143
Padova 122
Nanjing 115
Westminster 115
Lomé 109
Rome 104
Tokyo 103
Berlin 98
Buffalo 97
Jacksonville 95
Helsinki 91
Redmond 84
Turin 84
Jinan 82
Medford 79
Modena 78
Lahore 73
Guangzhou 71
Naples 71
Cesena 70
Shanghai 69
Da Nang 67
Munich 62
Saint Petersburg 62
Shenyang 60
São Paulo 60
Florence 57
Dearborn 56
Johannesburg 54
Bengaluru 50
Orem 49
Abeokuta 48
Amman 48
Changsha 48
Chicago 48
Gujranwala 48
Haiphong 48
Rimini 47
Nanchang 45
Phoenix 45
Tianjin 45
Toronto 45
Redondo Beach 44
Hebei 43
London 43
Sofia 43
San Francisco 42
The Dalles 42
Brussels 41
Denver 41
San Diego 41
Amsterdam 39
Brooklyn 39
Jakarta 39
Atlanta 36
Montreal 36
Padua 36
Warsaw 35
Redwood City 32
Tukwila 32
Des Moines 29
Forlì 28
Basingstoke 27
Bern 27
Falls Church 27
Hangzhou 27
Shenzhen 27
Pune 26
Zhengzhou 26
Totale 17.771
Salva come PNG Salva come JPEG
Nome #
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 743
Lactobacillus Biofilms Influence Anti-Candida Activity 734
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 541
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 495
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 410
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 354
Isolation of vaginal lactobacilli and characterization of anti-candida activity 303
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 300
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 289
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 283
Impact of fermented soy beverages containing selected vaginal probiotics on the in vitro fecal microbiota of post-menopausal women 280
Azithromycin-loaded liposomes and niosomes for the treatment of skin infections: influence of excipients and preparative methods on the functional properties 276
Development and characterization of fermented soy beverages containing encapsulated or non-encapsulated vaginal probiotics 272
Development of a Fermented Milk Designed for Women's Well-Being Containing an Exopolysaccharides-Producing Starter Culture and a Functional Vaginal Strain 259
A peptidic hydrogel that may behave as a "trojan Horse" 254
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 249
Genotypic and phenotypic characterization of Lactobacillus strains with antipathogenic activities 248
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 239
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 236
Determination of antibacterial and technological properties of vaginal lactobacilli for their potential application in dairy products 228
Development of azithromycin-loaded microemulsions for the treatment of skin infections 227
Diversity of vaginal microbiome and metabolome during genital infections 227
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 226
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 223
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 221
ANTITUMOR ACTIVITY OF INDOLE-DERIVATIVES IN THE HUMAN OVARIAN CANCER CELL LINE IGROV-1 221
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 221
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 219
A new EGFR inhibitor induces apoptosis in colon cancer cells. 218
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 217
VAGINAL MICROBIOME FOR THE PRESERVATION OF WOMEN’S HEALTH USING FOOD STRATEGY 217
ANTITUMOR ACTIVITY OF NEW SUBSTITUTED 3-(5- IMIDAZO[2,1-b]THIAZOLYLMETHYLENE)-2-INDOLINONES 215
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 213
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 212
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 212
Computer vision approach for the determination of microbial concentration and growth kinetics using a low cost sensor system 211
Azithromycin-loaded vesicles for the treatment of skin infections: a comparative study of different formulations 208
Unpredictable Dynamic Behaviour of Ruthenium Chelate Pyrrole Derivatives 207
(R)-9-HSA HAS A MORE REMARKABLE ANTIPROLIFERATIVE EFFECT COMPARE TO (S)-9-HSA. 205
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 205
Designing fermented milk with targeted probiotics: a step toward female-focused functional foods 204
Insight into phenotypic and genotypic differences between vaginal Lactobacillus crispatus BC5 and Lactobacillus gasseri BC12 to unravel nutritional and stress factors influencing their metabolic activity 204
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 202
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 199
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 199
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 199
9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma 197
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 196
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 192
Development and Characterization of Azithromycin-Loaded Microemulsions: A Promising Tool for the Treatment of Bacterial Skin Infections 190
Bacterial concentration detection using a portable embedded sensor system for environmental monitoring 190
A NEW EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR IN COLON CANCER CELLS 190
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 188
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 185
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 185
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 183
In-vitro effect of vaginal lactobacilli against group B Streptococcus 182
Use of Lactobacillus crispatus to produce a probiotic cheese as potential gender food for preventing gynaecological infections 180
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis 179
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 173
Evaluation of the fate of Lactobacillus crispatus BC4, carried in Squacquerone cheese, throughout the simulator of the human intestinal microbial ecosystem (SHIME) 173
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 173
Human Breast Milk: A Source of Potential Probiotic Candidates 172
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 171
Electrical Impedance Spectroscopy (EIS) characterization of saline solutions with a low-cost portable measurement system 169
Metabolic profiling of Candida clinical isolates of different species and infection sources 168
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 167
Efficacy and Safety of a Multistrain Probiotic Formulation Depends from Manufacturing 167
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 167
NUCLEAR REDISTRIBUTION OF EXOGENOUS ADMINISTERED 9- AND 10-HSA, ANALYZED BY MASS SPECTROMETRY 166
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 166
Mucoadhesive Buccal Films for Local Delivery of Lactobacillus brevis 166
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 166
Redox Signaling via Lipid Peroxidation Regulates Retinal Progenitor Cell Differentiation. 164
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 163
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 160
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 160
Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues 160
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 157
null 156
Modulation of apoptotic signalling by 9-hydroxystearic acid in osteosarcoma cells 156
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 156
CYTOTOXICITY EVALUATION OF A POLYAMINE-QUINONE LIBRARY CONJUGATES IN HUMAN COLON CARCINOMA CELLS 155
Lactobacillus crispatus to produce a functional cheese as dietary strategy to improve woman wellbeing 154
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 154
Vaginal microbiome signatures in Chlamydia trachomatis infected women 153
Probiotic and metabolic characterization of vaginal lactobacilli for a potential use in functional foods 152
Unravelling the functional and technological potential of soy milk based microencapsulated Lactobacillus crispatus and Lactobacillus gasseri 151
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 149
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 148
A portable sensor system for bacterial concentration monitoring in metalworking fluids 148
Surfactant-enriched liposomes to enhance azithromycin efficacy in Chlamydia trachomatis infections 148
THE INDOLE-DERIVATIVE 3L INTERFERES WITH ESTROGEN RECEPTOR SIGNALLING IN IGROV 1 OVARIAN CANCER CELLS 147
Development and validation of a new phylogenetic DNA-microarray specific for the oral microbiota 146
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 146
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 145
THE HEALTH-PROMOTING EFFECT OF EXTRACELLULAR VESICLES RELEASED BY VAGINAL LACTOBACILLI 144
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 144
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 144
Association of Lactobacillus crispatus with fructo-oligosaccharides and ascorbic acid in hydroxypropyl methylcellulose vaginal insert 144
Totale 21.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.758
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021749 0 0 0 0 0 0 0 0 0 0 0 749
2021/20222.631 315 126 149 110 231 154 92 170 103 193 511 477
2022/20233.178 310 450 193 401 230 241 85 174 497 186 217 194
2023/20241.941 107 168 103 138 162 374 209 353 56 94 108 69
2024/20254.673 230 503 448 361 680 261 431 229 131 334 296 769
2025/202611.846 893 990 843 754 1.086 612 1.364 451 1.926 895 1.334 698
Totale 30.184